- Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 16 October 2020 Jiangdong Huo
- A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy 18 August 2020 Xiaoniu Miao
- Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication 9 August 2020 Helene Borrmann
- Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient 2 August 2020 Daming Zhou
- ADAM17-triggered TNF signalling protects the ageing Drosophila retina from lipid droplet-mediated degeneration 28 July 2020 Sonia Muliyil
- Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 15 July 2020 Jiangdong Huo
- Large-Scale Production of Human iPSC-Derived Macrophages for Drug Screening 11 July 2020 Simon Gutbier
- Profiling of naïve and primed human pluripotent stem cells reveals state-associated miRNAs 1 July 2020 Benjamin T Dodsworth
- Rates of homology directed repair of CRISPR-Cas9 induced double strand breaks are lower in naïve compared to primed human pluripotent stem cells 11 June 2020 Benjamin T Dodsworth
- Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair 7 June 2020 Nidaa A Ababneh
Javier Gilbert jaramillo
DPhil Student | Linacre College | email@example.com
I finished my major in Biology with honours from the ESPOL Polytechnic University (Guayaquil – Ecuador) in 2014. During my undergraduate studies, I collaborated with the Antarctic Chilean Institute researching on genetic biomarkers of climate change and pollution using the Antarctic sea urchin (S. neumayeri) as a model. In 2015, I was awarded with a scholarship from the Ecuadorian National Government to conduct my MRes studies in Translational Neurology at UCL, where I joined Isaacs’ lab. My research consisted on the development of a biomarker for C9orf72 ALS/FTD. After obtaining a distinction degree, I was recruited as a Junior Lecturer/Researcher in the Faculty of Life Sciences (ESPOL). My field of research included biomarker analysis for novel nutritional therapies in neuropsychiatry disorders. I conducted one of the first pilot studies using the ketogenic diet as a treatment for schizophrenia and schizoaffective disorders in collaboration with Christopher Palmer, MD-PhD (McLean Hospital, Harvard Medical School). Currently, I remain holding the scholarship from the Ecuadorian National Government to conduct my DPhil studies at the Dunn School of Pathology, University of Oxford.
My field of research is related to nutrient energy metabolism of the early human brain in health and disease. Currently, my DPhil research project is aiming to elucidate the connection between native immunity and metabolic dysregulation/shift in progenitor brain cells during Zika virus infection, as the cause of different brain abnormalities, particularly microcephaly.